EWA
BLTE

EverSource Wealth Advisors’s Belite Bio BLTE Stock Holding History

EverSource Wealth Advisors’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$924 Sell
6
-1,602
-100% -$246K ﹤0.01% 3991
2026
Q1 		$256K Buy
1,608
+10
+0.6% +$1.68K 0.01% 922
2025
Q4 		$256K Sell
1,598
-108
-6% -$12.8K 0.01% 835
2025
Q3 		$126K Sell
1,706
-844
-33% -$55.4K 0.01% 1155
2025
Q2 		$147K Buy
+2,550
New +$156K 0.01% 1009

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
HNWAG
High Net Worth Advisory Group Naples, Florida $471M AUM 22.07% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return

EverSource Wealth Advisors's BLTE Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Belite Bio (BLTE) stake by 100% in Q2 2026, selling an estimated $246K and leaving 6 shares worth $924. The position accounts for ﹤0.01% of the portfolio, ranked #3991.

EverSource Wealth Advisors first reported a position in BLTE in Q2 2025 and has held it in 5 quarters since. The position peaked at $256K in Q1 2026. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • EverSource Wealth Advisors held 6 shares of Belite Bio worth $924 as of Q2 2026.
  • EverSource Wealth Advisors sold 1,602 Belite Bio shares in Q2 2026, an estimated $246K.
  • Belite Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3991 holding.
  • EverSource Wealth Advisors first reported a position in Belite Bio in Q2 2025 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's Belite Bio position peaked at $256K in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.